Literature DB >> 34213695

Treatment of focal hand dystonia: current status.

Navnika Gupta1, Sanjay Pandey2.   

Abstract

BACKGROUND: Focal hand dystonia (FHD) is usually adult-onset focal dystonia that can be associated with marked occupational and functional disability leading to reduced quality of life.
METHODS: Relevant studies on treatment options for FHD, their limitations, and current recommendations were reviewed using the PubMed search until March 31, 2021. Besides, the reference lists of the retrieved publications were manually searched to explore other relevant studies.
RESULTS: and conclusion Currently, botulinum toxin has the best evidence for treatment of FHD, and 20-90% of patients experience symptomatic improvement. However, its benefit is often limited by the reduction of muscle tonus acting on the muscle spindle. Different surgical modalities that have been used to treat focal hand dystonia include lesional surgery, deep brain stimulation, and magnetic resonance-guided focused ultrasound thalamotomy. Recent studies exploring the role of behavioral techniques, sensorimotor training, and neuromodulation for the treatment of focal hand dystonia have reported good outcomes, but larger studies are required before implementing these interventions in practice.

Entities:  

Keywords:  Botulinum toxin; DBS; Hand dystonia; Lesional surgery; Neuromodulation; Neurorehabilitation

Year:  2021        PMID: 34213695     DOI: 10.1007/s10072-021-05432-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  69 in total

1.  Writer's cramp: treatment with botulinum toxin injections.

Authors:  J Rivest; A J Lees; C D Marsden
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

2.  Botulinum toxin injections in the treatment of musician's dystonia.

Authors:  Stephan Schuele; Hans-Christian Jabusch; Richard J Lederman; Eckart Altenmüller
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

Review 3.  Phenomenology and classification of dystonia: a consensus update.

Authors:  Alberto Albanese; Kailash Bhatia; Susan B Bressman; Mahlon R Delong; Stanley Fahn; Victor S C Fung; Mark Hallett; Joseph Jankovic; Hyder A Jinnah; Christine Klein; Anthony E Lang; Jonathan W Mink; Jan K Teller
Journal:  Mov Disord       Date:  2013-05-06       Impact factor: 10.338

4.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.

Authors:  J Jankovic; K Schwartz; D T Donovan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

Review 5.  Task-specific dystonias: a review.

Authors:  Diego Torres-Russotto; Joel S Perlmutter
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

6.  Writer's cramp: the experience with botulinum toxin injections in 25 patients.

Authors:  N Poungvarin
Journal:  J Med Assoc Thai       Date:  1991-05

7.  Treatment of focal dystonias of the hand with botulinum toxin injections.

Authors:  L G Cohen; M Hallett; B D Geller; F Hochberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

Review 8.  Treatment of focal dystonias with botulinum neurotoxin.

Authors:  Mark Hallett; Reiner Benecke; Andrew Blitzer; Cynthia L Comella
Journal:  Toxicon       Date:  2008-12-13       Impact factor: 3.033

9.  Acute anticholinergic action in focal dystonia.

Authors:  A E Lang; M P Sheehy; C D Marsden
Journal:  Adv Neurol       Date:  1983

10.  Writers' cramp-a focal dystonia.

Authors:  M P Sheehy; C D Marsden
Journal:  Brain       Date:  1982-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.